Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, December 5, 2023.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Crossroads (+60) - BCLI is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid BCLI?
MarketClub looks at technical strength and momentum to determine if the timing is right for BCLI.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BCLI
The long-term trend has been DOWN since Jul 6th, 2023 at 1.9800
The intermediate-term trend has been UP since Nov 13th, 2023 at 0.1833
The short-term trend has been UP since Nov 30th, 2023 at 0.2450
Smart Scan Analysis for BCLI
Based on our trend formula, BCLI is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.440 | 0.450 | 0.298 | 0.300 | -0.100 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.400 | 12392224 | 2023-12-05 15:59:55 |
| Year High | 5.35 | Year High Date | 2018-06-04 |
| Year Low | 2.88 | Year Low Date | 2018-02-09 |
| 52wk High | 3.46 | 52wk High Date | 2023-03-31 |
| 52wk Low | 0.134 | 52wk Low Date | 2023-10-31 |
| Year End Close | 0.223 | Average Volume | 3,226,051 |
| Shares Outstanding | 48,982 | % Institutional | 19.6 |
| Market Cap | 91M | Assets | 5,747,000M |
| Liabilities | 9,629,000M | P/E Ratio | -0.34730000 |
| Beta | 0.8 | Volatility | 39.71 |